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Articular cartilageSeveral processing technologies and engineering strategies have been combined to create scaffolds with
superior performance for efficient tissue regeneration. Cartilage tissue is a good example of that, present-
ing limited self-healing capacity together with a high elasticity and load-bearing properties. In this work,
novel porous silk fibroin (SF) scaffolds derived from horseradish peroxidase (HRP)-mediated crosslinking
of highly concentrated aqueous SF solution (16 wt%) in combination with salt-leaching and freeze-drying
methodologies were developed for articular cartilage tissue engineering (TE) applications. The
HRP-crosslinked SF scaffolds presented high porosity (89.3 ± 0.6%), wide pore distribution and high inter-
connectivity (95.9 ± 0.8%). Moreover, a large swelling capacity and favorable degradation rate were
observed up to 30 days, maintaining the porous-like structure and b-sheet conformational integrity
obtained with salt-leaching and freeze-drying processing. The in vitro studies supported human
adipose-derived stem cells (hASCs) adhesion, proliferation, and high glycosaminoglycans (GAGs) synthe-
sis under chondrogenic culture conditions. Furthermore, the chondrogenic differentiation of hASCs was
assessed by the expression of chondrogenic-related markers (collagen type II, Sox-9 and Aggrecan) and
deposition of cartilage-specific extracellular matrix for up to 28 days. The cartilage engineered constructs
also presented structural integrity as their mechanical properties were improved after chondrogenic cul-
turing. Subcutaneous implantation of the scaffolds in CD-1 mice demonstrated no necrosis or calcifica-
tion, and deeply tissue ingrowth. Collectively, the structural properties and biological performance of
these porous HRP-crosslinked SF scaffolds make them promising candidates for cartilage regeneration.
Statement of Significance
In cartilage tissue engineering (TE), several processing technologies have been combined to create scaf-
folds for efficient tissue repair. In our study, we propose novel silk fibroin (SF) scaffolds derived from
enzymatically crosslinked SF hydrogels processed by salt-leaching and freeze-drying technologies, for
articular cartilage applications. Though these scaffolds, we were able to combine the elastic properties
of hydrogel-based systems, with the stability, resilience and controlled porosity of scaffolds processed
via salt-leaching and freeze-drying technologies. SF protein has been extensively explored for TE applica-
tions, as a result of its mechanical strength, elasticity, biocompatibility, and biodegradability. Thus, the
structural, mechanical and biological performance of the proposed scaffolds potentiates their use as
three-dimensional matrices for cartilage regeneration.
 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.arters of
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Articular cartilage is a highly-organized tissue with avascular
properties and limited intrinsic healing capacity [1]. Injuries and
degenerative conditions may compromise cartilage functions and
cause pain and disability to the patients. A study performed by
Widuchowski et al. [2] involving 25,124 knee arthroscopies
showed chondral lesions in 60% of the cases, classified as focal
chondral lesions (67%), osteoarthritis (29%), osteochondritis disse-
cans (2%) and other types of lesions (1%). Surgical procedures
remain the standard treatment for injured and degenerative joint
pathologies, which may include early surgical interventions, such
us osteotomy, autologous osteochondral graft transplantation
and arthroscopic microfracture chondroplasty, or the total tissue
replacement applied in cases of end-stage degenerative patholo-
gies [3]. Thus, the real challenge for orthopaedic surgeons is still
the management of articular cartilage defects, whose treatment
options are in most cases only for symptom relief and do not
ensure the long-term healing of tissue.
Bioactive substitutes emerged over the past years as possible
solutions for the treatment and regeneration of articular cartilage
tissue [1]. For example, a clinical success has been obtained since
1994 through the use of autologous chondrocytes implantation
(ACI) techniques directly at the cartilage defects [4]. Since then,
cartilage tissue engineering (TE) strategies have been proposed as
cell-free or cell-based approaches, combined with biomimetic
materials as supporting matrices [5]. The clinical use of scaffolds
in cartilage regeneration is represented only by a few examples
of commercially available products, including the Chondro-Gide
(Geistlich Pharma AG, Wolhusen, Switzerland) collagen scaffold
that presented promising results for mid-long-term cartilage treat-
ment [6]. The inclusion of interconnected porous-like structures
showed to benefit cell adhesion and guided a rapid extracellular
matrix (ECM) formation and infiltration within the scaffolds, which
represents great advancements on cartilage tissue regeneration,
especially when envisioning the use of cell-free strategies [7,8].
On the other hand, different polymeric-based hydrogels have been
investigated as injectable systems for arthroscopic insertion
approaches [9]. The high-water-content that mimics the native
cartilage tissue, or the ability to encapsulate cells and diffuse
growth factors may benefit this technology [10]. Gelrin C (Regen-
tis, Haifa, Isreal) and ChonDuxTM (Cartilix, CA, USA) hydrogels com-
posed of polyethylene glycol (PEG) covalently bonded to fibrinogen
chains and to hyaluronic acid, respectively, are two good examples
of biocompatible and bioabsorbable injectable system that have
been successfully used in clinic to fill and reinforce micro-
fractured cartilage defects [11].
Silk fibroin (SF) solutions have been used to prepare hydrogels
as injectable or non-injectable systems, with suitable mechanical
properties for load bearing of cartilage tissue [12–14]. Most of
these hydrogels are formed in a sol-gel transition, together with
a structure conformation transition from amorphous to b-sheet,
which can happen by means of different physical and chemical
treatments [15]. Different authors have shown that the addition
of organic solvents (methanol) [16], decreasing the pH value [17]
or increasing the temperature/ionic species (Ca2+) concentration
[18] in the aqueous SF solution, can induce SF hydrogels formation
with gelation times that can range from a few hours to days,
depending on the applied method. Moreover, in cases where cell
encapsulation is desired, some of these methods may be compro-
mised. For example, the use of methanol as crosslinking agent
imply the immersion of SF solution into the solvent until the reac-
tion is complete and the hydrogel formed. This way, the cell encap-
sulation process would be compromised, since cells would not
survive in the presence of methanol solution. Nevertheless, thisPlease cite this article in press as: V.P. Ribeiro et al., Combinatory approach for
(2018), https://doi.org/10.1016/j.actbio.2018.03.047process does not invalidate the methanol-induced SF hydrogels
for cell-seeding approaches [19]. The use of external stimuli-like
ultrasonication and mechanical agitation, have also been explored
to produce fast-formed SF hydrogels, compatible for cell encapsu-
lation [20,21]. Also, several enzymatically mediated crosslinking
methods have been used to prepare in situ formed hydrogels. Com-
paring to other systems, enzyme-mediated crosslinking can dis-
play several advantages. They occur at physiological conditions
and the gelation time can be easily tuned to be fast, favouring cell
encapsulation and the delivery of bioactive molecules [22].
Recently, the horseradish peroxidase (HRP) mediated crosslinking
has received an increasing interest, since the phenol groups in tyr-
osine, tyramine or aminophenol, can be conjugated when cat-
alyzed by peroxidase and hydrogen peroxide (H2O2) [23,24].
Considering that SF protein contains some reactive amino acid resi-
dues of tyrosine (5%), this was seen as a great advantage to create
naturally induced SF hydrogels [16,25]. These HRP-mediated cross-
linked SF hydrogels were previously produced in a main amor-
phous conformation and at physiological conditions, showing
promising biological results and tunable mechanical properties
according to the protein/crosslinker concentration. Simultane-
ously, it has been recognized that the anti-parallel b-sheets forma-
tion in SF hydrogels or scaffolds can affect their stiffness,
degradability and biological behavior in response to changes in
surface roughness [26]. For example, Yan et al. [27] combined
salt-leaching and freeze-drying methodologies to produce
macro/microporous SF scaffolds, showing that the anti-parallel
b-sheet conformation was present in the scaffolds and improved
their mechanical properties for cartilage TE scaffolding strategies.
Moreover, high and controlled porosity induced by the salt-
leaching technique have also shown to improve cell adhesion, prolif-
eration and chondrogenic differentiation within SF constructs [14].
On the side of the cells, the combination of three-dimensional
(3D) networks with autologous chondrocytes previous implanta-
tion, represented significant clinical improvements for cartilage
defects treatment (see NeoCart, Histogenics, Waltham, MA and
Hyalograft C, Anika Therapeutics, Bedford, MA) [28,29]. Neverthe-
less, great attention has been directed for cell sources able to dif-
ferentiate into the chondrogenic lineage, and secret growth
factors responsible for creating an ECM that can fill the chondral
lesion [30]. The application of human mesenchymal stem cells
(MSCs) covered a noticeable interest having shown to possess mul-
tilineage differentiation potential including for chondrogenesis
induction [31]. On the other hand, human adipose-derived stem
cells (hASCs) appear to present the same multilineage differentia-
tion potential as MSCs, but also demonstrated special features
regarding cell surface markers and abundance in the body. More-
over, they can be easily harvested from the adipose tissue with less
pain for the donor [32]. Previous studies, were able to explore the
chondrogenic differentiation potential of hASCs when cultured in
SF scaffold materials, showing that the 3D porous matrices suc-
cessfully induced cell-cell interactions and ECM matrix formation
in a similar fashion to the forming cartilage tissue [33,34].
In the present work, we aimed to make use of an enzymatic-
mediated approach to crosslink SF combined with salt-leaching
and freeze-drying technologies, towards producing robust and
interconnected porous SF scaffolds for cartilage TE applications.
With this strategy, it is expected to tune a large number of proper-
ties in a single HRP-crosslinked SF scaffold, while avoiding the use
of harsh or toxic crosslinking agents during processing. These work
reports on the effectiveness of the proposed scaffolds over in vitro
chondrogenic differentiation and in vivo compatibility, being the
first study to propose such combinatory approaches for the devel-
opment of a more complete SF scaffold able to better recreate the
requirements for the treatment of cartilage defects.developing silk fibroin scaffolds for cartilage regeneration, Acta Biomater.
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2.1. Materials and reagents
Silk derived from the silkworm Bombyx mori in the form of
cocoons was provided by the Portuguese Association of Parents
and Friends of Mentally Disabled Citizens (APPACDM, Castelo
Branco, Portugal). Silicone tubing was purchased from Deltalab
(Barcelona, Spain). Granular sodium chloride (Commercial grade,
Portugal) was prepared in the range of 500–1000 mm in an analytic
sieve shaker (AS 200 Digit, Retsch, Germany). All reagents were
purchased from Sigma-Aldrich (St. Louis, MO, USA) unless other-
wise stated.
2.2. Preparation of aqueous silk fibroin solution
Purified silk fibroin (SF) was prepared by removing the glue-like
protein sericine from the cocoons in a boiling sodium carbonate
solution (0.02 M) for 1 h and then rinsed with distilled water in
order to fully remove the degumming solution. A 9.3 M lithium
bromide solution was used to dissolve the purified SF for 1 h at
70 C and dialyzed in distilled water for 48 h using a benzoylated
dialysis tubing (MWCO: 2 kDa). Next, the aqueous SF solution
was concentrated using a 20 wt% poly(ethylene glycol) solution
for at least 6 h. The final concentration of SF (18–20 wt%) was
determined by measuring the dry weight of the SF solution placedFig. 1. Schematic illustration of the experimental setup proposed in this study. (a) Purific
the HRP-crosslinked SF scaffolds, combining the HRP-mediated crosslinking of highly co
Temporal approach followed (c) to induce the chondrogenic differentiation of hASCs into
crosslinked SF scaffolds. The diameter and height of scaffolds were 8 mm and 4 mm, re
Please cite this article in press as: V.P. Ribeiro et al., Combinatory approach for
(2018), https://doi.org/10.1016/j.actbio.2018.03.047in the oven at 70 C overnight. Meanwhile, the prepared SF solu-
tion was stored at 4 C until further use (Fig. 1a).2.3. Preparation of salt-leached enzymatically crosslinked silk fibroin
scaffolds
Enzymatically crosslinked SF scaffolds were prepared by the ini-
tial mixture of SF solution, diluted to 16 wt%, with horseradish per-
oxidase solution (HRP type VI, 0.84 mg/mL) and hydrogen peroxide
solution (H2O2, 0.36 wt%; Panreac, Barcelona, Spain), as reported
previously [16]. Briefly, 1 mL SF solution, 50 mL HRP solution and
65 mL H2O2 solution (1/0.26%/1.45%) were mixed in a 1.5 mL cen-
trifuge tube (Eppendorf, Hamburg, Germany) and before gelling,
1 mL of the SF/HRP/H2O2 solution was transferred into a cylindrical
shaped silicone mold (9 mm inner diameter). b-sheet induced SF
structures were prepared by the slow addition of 2 g of granular
sodium chloride (particle size 500–1000 mm) to the solution. The
sodium chloride particles were gently added to the silicon molds
to facilitate the precipitation of the salt [27]. The molds were
placed in the oven at 37 C to complete the enzymatic reaction at
the SF/HRP/H2O2 complex. HRP-crosslinked SF scaffolds were
formed when the undissolved sodium chloride particles was lea-
ched out (porogen) in distilled water for 72 h. Finally, the scaffolds
were removed from the molds by using a biopsy punch (8 mm
inner diameter; Smith & Nephew, Portugal), followed by freezingation process for producing aqueous SF solution. (b) Methodology used for preparing
ncentrated SF solution (16 wt%) with salt-leaching and freeze-drying technologies.
the scaffolds, and (d) for in vivo evaluation of the subcutaneously implanted HRP-
spectively.
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lona, Spain) for 7 days (Fig. 1b).2.4. Physicochemical characterization
2.4.1. Scanning electron microscopy
The surface and cross-sectional morphology of the HRP-
crosslinked SF scaffolds was analyzed by analytic scanning electron
microscopy (SEM) using a JEOL JSM-6010LV (Tokyo, Japan). Two
samples were used for structure qualitative evaluation. Prior anal-
ysis all samples were sputter-coated with gold using a Leica EM
ACE600 coater (Leica Microsystems, Wien, Austria).2.4.2. Micro-computed tomography
The microstructure of the prepared HRP-crosslinked SF scaf-
folds was evaluated using a high-resolution X-ray microtomogra-
phy system Skyscan 1072 scanner (Skyscan, Kontich, Belgium).
Samples were scanned using a pixel size of 8.79 mm x/y/z and an
X-ray source fixed at 40 keV of energy and 248 mA of current. After
acquisition, reconstructed grey-scale images were converted into
binary images by using a dynamic threshold of 40–255. Then, the
binary images were used for morphometric analysis (CT Analyzer
v1.12.0.0, SkyScan, Kontich, Belgium) by quantification of porosity,
mean pore size, mean wall thickness and interconnectivity. The
scaffolds cross-sectional images and 3D virtual models were also
created, visualized and registered using the image processing and
reconstruction software’s Data Viewer (v1.6.6.0) and CT-Vox
(v2.0.0) (SkyScan, Kontich, Belgium), respectively. Three samples
were used for the qualitative and quantitative microstructure
evaluation.2.4.3. Fourier transform infrared spectroscopy
The infrared spectra of the HRP-crosslinked SF scaffolds were
recorded by Fourier transform infrared (FTIR) spectroscopy
(Perkin-Elmer 1600 series equipment, CA, USA) under an attenu-
ated total reflectance (ATR) model (IRPrestige-21, Shimadzu,
Kyoto, Japan), equipped with a germanium crystal. Prior analysis,
the samples were immersed in phosphate-buffered saline (PBS,
pH 7.4) solution until equilibrium was reached (overnight). All
spectra were obtained between 4500 and 800 cm1 at a 4 cm1
resolution with 32 scans. Three samples were used for analysis
and PBS was used as background.2.4.4. Compressive tests
The mechanical behavior of the HRP-crosslinked SF scaffolds
was tested under quasi-static compression in dry and hydrated
state using a Universal Testing Machine (Instron 4505, Norwood,
MA, USA). The diameter and height of the scaffolds were 8 and
4 mm, respectively. Prior analysis, the samples tested in hydrated
state were immersed in PBS solution (pH 7.4) until equilibrium
was reached (overnight). The cross-head speed was fixed at
2 mm/min and tests were run until a 60% reduction in sample
height had been achieved. The compressive stress and strain were
graphed and the average compressive modulus and compressive
strength were determined based on five samples measured for
each group. The elastic modulus (E) or Young’s modulus for com-
pression was defined by the slope of the initial linear region of
the stress-strain curve, described as elastic deformation region. A
plastic deformation state was reached in the following linear
region, above the yield point, until the densification and complete
collapse of material at the final region of the stress-strain curve, in
which the stress rises substantially. The compressive strength was
determined by the maximum compressive load (N) applied in the
test divided by the original area of the specimen (mm2).Please cite this article in press as: V.P. Ribeiro et al., Combinatory approach for
(2018), https://doi.org/10.1016/j.actbio.2018.03.0472.5. Swelling ratio and degradation profile
The swelling ratio of the HRP-crosslinked SF scaffolds was
tested in PBS solution. The initial dry weight of each sample
(n = 6) was measured, and then the scaffolds were immersed in
5 mL of PBS solution. The study was conducted at 37 C for a time
period ranging from 1 h to 30 days. The solutions were changed
weekly. At the end of each time point, samples were gently blotted
with filter paper to remove excess liquid and the wet weight
measured. The swelling ratio was determined as:
Water uptake ð%Þ ¼ mwmi
mi
 100
where mw is the weight of the sample after removal from the solu-
tion and mi is the initial weight of the sample.
The stability of the HRP-crosslinked SF scaffolds was evaluated
by enzymatic degradation test. Protease XIV was derived from
Streptomyces griseus (3.5 U/mg) and prepared at 3.5 U/mL and
0.2 U/mL by dissolving the enzyme in PBS [35]. As control
condition, samples were incubated in PBS solution alone. The ini-
tial dry weight of each sample (n = 3) was measured, and then
the scaffolds were immersed in 5 mL of protease solution or PBS
solution. The study was conducted at 37 C for a time period rang-
ing from 3 h to 30 days. The enzyme solutions were changed every
24 h. The dry weight was measured after washing the samples
with distilled water and drying at 70 C overnight. The weight loss
was determined as:
Weight loss ð%Þ ¼ mimf
mi
 100
where mi is the initial weight of the sample and mf is the weight of
the sample after drying.
2.6. In vitro cell studies
2.6.1. hASCs isolation and expansion
Human abdominal subcutaneous adipose tissue samples were
obtained from lipoaspiration procedures performed on healthy
male and female donors with ages between 18 and 57 years, after
informed consent, under established cooperative agreements
between Hospital da Senhora da Oliveira (Guimarães, Portugal)
and 3B’s Research Group. All the samples were processed within
24 h after the lipoaspiration procedure and human adipose-
derived stem cells (hASCs) were enzymatically isolated from sub-
cutaneous adipose tissue as previously described [36]. Human
ASCs were expanded in basal medium consisting of MEM alpha
medium (a-MEM; Gibco, Life Technologies, Carlsbad, CA, USA)
supplemented with sodium bicarbonate, 10% (v/v) fetal bovine
serum (FBS; Life Technologies, Carlsbad, CA, USA) and 1% (v/v)
antibiotic/antimycotic solution (final concentration of penicillin
100 units/mL and streptomycin 100 mg/mL, Life Technologies,
Carlsbad, CA, USA). Cells were cultured until confluence at 37 C,
5% CO2 incubator, changing the culture medium every 2–3 days.
2.6.2. Seeding and chondrogenic differentiation of hASCs on the HRP-
crosslinked SF scaffolds
Human ASCs were characterized by flow cytometry (FACSCal-
ibur flow cytometer, BD Biosciences, San Jose, CA, USA) for MSCs
surface markers [37]. The following monoclonal antibodies
conjugated to fluorochromes were used: anti-CD105 FITC (BioRad,
Hercules, CA, USA), anti-CD73 PE, anti-CD90 APC, anti-CD45 FITC,
anti-CD34 PE (BD Biosciences, San Jose, CA, USA). HRP-
crosslinked SF scaffolds of 8 mm in diameter and 4 mm in height
were used for the in vitro studies and sterilized by ethylene oxide
(Gas Sterilizer/Aerator, Steri-Vac 5XL, 3 M company, St. Paul, MN,
USA). The number of cell-seeded constructs used for the differentdeveloping silk fibroin scaffolds for cartilage regeneration, Acta Biomater.
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seeding, all scaffolds were hydrated in Dulbecco’s modified Eagle’s
medium-high glucose (DMEM-HG; Gibco, Life Technologies,
Carlsbad, CA, USA) supplemented with 1% (v/v) antibiotic/antimy-
cotic solution, overnight in the CO2 incubator. In the following day,
the hydrated scaffolds were transferred to 48-well suspension cell
culture plates (Cellstar, Greiner Bio-One, Kremsmuenster Austria).
Confluent hASCs (passage 2) were detached with TrypLETM Express
(Life Technologies, Carlsbad, CA, USA) and seeded in a 20 mL
cell suspension onto the surface of the scaffolds, at a density of
3  105 cells/scaffold. The constructs were kept in the CO2 incuba-
tor for 3 h and then completed with 1 mL of DMEM-HG supple-
mented with 10% (v/v) FBS (Life Technologies, Carlsbad, CA, USA)
and 1% (v/v) antibiotic/antimycotic solution. After 24 h, the culture
medium was refreshed or replaced by chondrogenic differentiation
medium. The chondrogenic medium was based on DMEM-HG sup-
plemented with 50 mg/mL Ascorbic acid, 40 mg/mL L-Prolin, 1%
Insulin-Transferrin-Selenium-G (ITS-G; Life Technologies, Carls-
bad, CA, USA), 100 nM Dexamethasone, 10 ng/mL recombinant
human TGF-b1 (PeproTech, London, UK) and 1% (v/v) antibiotic/
antimycotic solution. Samples cultured in chondrogenic and basal
culture medium, were harvested after culturing for 1, 7, 14, 21
and 28 days and the culture medium was changed every 2–3 days
(Fig. 1c).
2.6.3. Live/Dead staining
Cell viability at the HRP-crosslinked SF constructs was
confirmed by performing a calcein-AM and propidium iodide (PI;
Life Technologies, Carlsbad, CA, USA) staining. At the end of each
time-point, three samples of each group (chondrogenic and basal
medium) were incubated in 1 mg/mL calcein-AM and 5 mg/mL PI
prepared in DMEM-low glucose supplemented with sodium bicar-
bonate and 1% (v/v) antibiotic/antimycotic solution, for 30 min in
the dark at 37 C in the CO2 incubator. After washing in PBS, sam-
ples were immediately examined under fluorescence microscopy
(Calcein-AM in green: ex/em 495/515 nm; PI in red: ex/em
495/635 nm) in a transmitted and reflected light microscope (Axio
Imager Z1 m; Zeiss, Jena, Germany). Images were acquired using
the Zen microscope processing software (Zeiss, Jena, Germany)
connected to a digital camera AxioCamMR3 (Zeiss, Jena, Germany).
A Z-stack function was used to combine images at different depths
into one final image.
2.6.4. Alamar blue assay
Alamar blue assay was performed to assess the metabolic activ-
ity of cells at the HRP-crosslinked SF constructs, following the
manufacturer’s instructions. After each culture time, the constructs
were transferred to a new 48-well suspension cell culture plate
and a solution of 10% (v/v) AlamarBlue (BioRad, Hercules, CA,
USA), prepared in chondrogenic or basal culture medium, was
transferred to the culture plates in 500 mL/scaffold. After 3 h of
reaction with cells at 37 C in the CO2 incubator, 100 mL of Alamar
blue solution were taken from each well and placed in a 96-well
white opaque plate (Corning-Costar Corporation, Acton, MA, USA)
in triplicate. The fluorescence was measured in a microplate reader
(Synergy HT, BioTek, Instruments, USA) at an excitation wave-
length of 530/25 nm and at an emission wavelength of 590/35 nm.
Three samples of each group (chondrogenic and basal medium)
were tested at each time-point, in three independent experiments.
Scaffolds without cells were used as control.
2.6.5. Quantitative DNA and glycosaminoglycans assays
The amount of double stranded DNA (dsDNA), that is directly
proportional to the cell number, was determined using a Quant-
IT PicoGreen dsDNA quantification kit (Life Technologies, Carlsbad,
CA, USA), according to the manufacturer’s instructions. After eachPlease cite this article in press as: V.P. Ribeiro et al., Combinatory approach for
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at 80 C in 1 mL of ultrapure water until further analysis. To
induce complete membrane lysis, samples were sonicated for 1 h
after thawed at room temperature (RT). Supernatant fluorescence
was measured using a microplate reader at an excitation wave-
length of 485/20 nm and at an emission wavelength of 528/20 nm.
The standard curve for DNA analysis was prepared with concentra-
tions ranging from 0 to 2 mg/mL.
A dimethylmethylene blue (DMB) assay was performed for gly-
cosaminoglycans (GAGs) quantification on the same samples used
for dsDNA quantification. Samples were digested overnight at 60
C in 1 mL papain digestion solution, prepared by adding to each
50 mL of digestion buffer, 25 mg of papain and 48 mg of n-acetyl
cysteine. Digestion buffer was composed of 200 mM of phosphate
buffer (sodium phosphate monobasic) containing 1 mM ethylene-
diaminetetraacetic acid (EDTA) (pH 6.8). Then, samples were cen-
trifuged at 13,000 rpm for 10 min and the supernatants collected.
GAGs content was spectrophotometrically determined with a
DMB solution, prepared by dissolving 16 mg DMB powder in 900
mL distilled water containing 3.04 g glycine and 2.73 g of NaCl
(Panreac Química SAU, Barcelona, Spain) (pH 3.0). The optical den-
sity (OD) was measured in a microplate reader at an absorbance of
530 nm. A chondroitin sulphate stock solution was prepared in dis-
tilled water at 50 lg/mL in order to make a standard curve with
concentrations ranging from 0 to 35 mg/mL. The obtained GAGs
concentrations were normalized against the DNA concentrations
of the same samples. Three samples of each group (chondrogenic
and basal medium) were tested at each time-point, in three inde-
pendent experiments. Scaffolds without cells were used as control.
2.6.6. Collagenous proteins quantification
The presence of collagen within the ECMwas determined by the
Sirius red/Fast green collagen staining kit (Chondrex, Redmond,
WA, USA), where the Sirius red dye specifically binds to collagen
and Fast green dye stains the non-collagenous proteins. After each
culture time, samples were washed with PBS solution and fixed
with 10% (v/v) formalin (Thermo Scientific, Waltham, MA, USA)
for 20 min at RT, washed again with PBS solution and stored at 4
C until further analysis. A mixture of 0.1% (v/v) Sirius red and
0.1% (v/v) Fast green solution saturated with picric acid was
transferred to the culture plates in 500 mL/scaffold. After 30 min
of incubation at RT, the dye solution was carefully removed and
samples were washed with distilled water. Afterwards, the dyes
were extracted from the stained samples by applying 2 mL of dye
extraction buffer (0.05 M NaOH solution in methanol). The OD
was measured in a microplate reader at an absorbance of 540 nm
and 605 nm. The amount of collagenous proteins was calculated
according to the manufacturer’s instructions. Three samples of
each group (chondrogenic and basal medium) were tested at each
time-point, in three independent experiments. Scaffolds without
cells were used as control.
2.6.7. RNA isolation and real-time reverse transcriptase-polymerase
chain reaction
The expression of mRNA for the genes of interest on the HRP-
crosslinked SF constructs was measured by real-time PCR analysis.
Total RNA was extracted from cells recovered from the 3D cultures
using Direct-zolTM RNA MiniPrep kit (Zymo Research, Irvine, CA,
USA), following the manufacturer’s instructions. After each culture
time, samples were washed with PBS solution, immersed in 700 mL
TRI Reagent and stored at 80 C until further use. Samples were
thawed at RT and sonicated for 15 min at 20 C to ensure the
complete lysing of the cells. RNA quantification and purity were
assessed using a NanoDrop ND-1000 spectrophotometer (Nano-
Drop Technologies, Wilmington, DE, USA). Samples with a
260/280 ratio between 1.6 and 2.0 were used for first-stranddeveloping silk fibroin scaffolds for cartilage regeneration, Acta Biomater.
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from the qScriptTM cDNA synthesis Kit (Quanta Biosciences,
Gaithersberg, MD, USA) in a MiniOpticon real-time PCR detection
system (BioRad, Hercules, CA, USA). Briefly, 100 ng of the total
RNA were used to generate single-stranded cDNA by random prim-
ing with qScript Reverse Transcriptase (RT). Afterwards, the
obtained cDNA was used as template for the amplification of the
target genes using the PerfeCta SYBR Green FastMix kit (Quanta
Biosciences, Gaithersberg, MD, USA) according to the manufac-
turer’s instructions. The primers sequence, specific for each gene,
namely glyceraldehyde-3-phosphate dehydrogenase (GAPDH), col-
lagen type II (Col II), Sox-9 and Aggrecan (ACAN) are described in
Table 1. Each real-time PCR run was carried out with an initial
incubation at 95 C for 2 min, followed by 45 cycles of denaturation
(95 C, 10 s), annealing (specific for each gene, 25 s) and extension
(72 C, 30 s) in a Mastercycler ep realplex real-time PCR system
(Eppendorf, Hamburg, Germany). The transcripts expression data
were normalized to the endogenous housekeeping gene GAPDH
and the relative quantification was calculated using as calibrators
the results obtained for each target gene at day 1 in basal culture
conditions, according to the Livak (2DDCT) method [38]. Three
samples of each group (chondrogenic and basal medium) were
tested at each time-point, in three independent experiments.2.6.8. Histology and immunofluorescence staining
At the end of each time-point, three HRP-crosslinked SF con-
structs from each group (chondrogenic and basal medium) were
fixed with 10% (v/v) formalin for 20 min at RT and transferred to
histological cassettes for paraffin-embedding. Samples were then
serially sectioned with 20 mm thick using a microtome (Spencer
820, American Optical Company, NY, USA). Representative sections
of the constructs were stained with standard Masson’s trichome,
using a Bio-Optica staining kit (Milan, Italy) to detect the fibrous
collagen content. Sirius red/Fast green collagen kit was also applied
as described in 2.6.6, for staining the collagen content with Sirius
red dye and counterstaining the non-collagenous proteins with
Fast green. Sections were also stained with Alcian blue 8GX (1%
v/v in 0.5 M acetic acid glacial; VWR BDH Prolabo, Briare, France)
and Safranin-O (0.1% v/v; Honeywell Fluka, Morris Plains, NJ,
USA) to detect the distribution and content of sulfated GAGs. For
Safranin-O staining, sections were counterstained with Gill-2
hematoxylin (Thermo Scientific, Waltham, MA, USA) and Fast
green (0.02% v/v; Honeywell Fluka, Morris Plains, NJ, USA).
To detect protein expression, antigen retrieval was performed
on the sections by incubating in 0.5% pepsin in 5 mM HCl (Fisher
Scientific, Waltham, MA, USA) for 30 min at 37 C. The sections
were permeabilized with 1% (v/v) Triton X-100/PBS for 10 min
and blocked in 3% (w/v) BSA/PBS for 1 h at RT. Immunolabeling
was performed using a mouse anti-human monoclonal antibody
against collagen type II (Col II; Chemicon, Temecula, CA, USA; dilu-
tion 1:5), a rabbit anti-human polyclonal antibody against Sox-9
(Milipore S.A.S, Molsheim, France; dilution 1:10) and a mouse
anti-human monoclonal antibody against Aggrecan (ACAN; clone
BC-3, Thermo Scientific, Waltham, MA, USA; dilution 1:5) as
primary antibodies, prepared in 1% (w/v) BSA/0.2% (v/v)Table 1
Primers list for the studied genes.
Gene Sequences
Forward (50-30) Reverse (50-30)
GADPH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG
Col II GACAATCTGGCTCCCAAC ACAGTCTTGCCCCACTTAC
Sox-9 TACGACTACACCGACCACCA TTAGGATCATCTCGGCCATC
ACAN TGAGTCCTCAAGCCTCCTGT TGGTCTGCAGCAGTTGATTC
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sections were incubated for 2 h at RT with the respective sec-
ondary fluorochrome-conjugated antibodies, anti-rabbit/mouse
IgG (Invitrogen, Life Technologies, California, USA; dilution
1:100), and with 4,6-Diamidino-2-phenyindole, dilactate (DAPI;
Biotium, CA, USA; dilution 1:500) for 15 min for nuclei staining.
Histological and immunofluorescent sections were observed
under transmitted and fluorescence microscopy (Col II and ACAN
in green: ex/em 488/517; Sox-9 in red: ex/em 594/618; DAPI in
blue: ex/em 358/461), respectively, using a transmitted and
reflected light microscope. Images were acquired using the digital
cameras AxioCam MRc5 and MR3, as described in 2.6.3. Scaffolds
without cells were used for staining control.2.6.9. Dynamic mechanical analysis
A dynamic mechanical analysis (DMA) was performed on the
HRP-crosslinked SF scaffolds and cell-seeded constructs after 28
days of culture in chondrogenic differentiation medium, using a
TRI-TEC8000B dynamic mechanical analyzer (Triton Technology,
Lincolnshire, UK) in the compressive mode [27]. The measure-
ments were carried out in the hydrated state at 37 C. The diameter
and height of the tested samples were 8 and 4 mm, respectively.
The samples were placed in a Teflon reservoir and clamped in
the DMA apparatus immersed in PBS solution. After equilibration
at 37 C, the DMA spectra were obtained in a frequency scan
between 0.1 and 10 Hz. A constant displacement amplitude of
50 mm was maintained during the experiments. Both storage mod-
ulus (E’) and loss factor (tan d) were obtained in the frequency
range. Before the analysis, a small pre-load of 0.1 N was applied
to each sample to ensure that the entire surface of the scaffold
was in contact with the compression plates, being the distance
between plates equal for all tested samples. At least four samples
were used for analysis.2.7. Subcutaneous implantation
In order to evaluate the in vivo biological response to the HRP-
crosslinked SF scaffolds, the scaffolds were subcutaneously
implanted in the back of twelve mice Hsd: ICR (CD-1) of 5 weeks
old and average weight of 27–32 g at the time of implantation
(Charles River Laboratories, Saint-Germain-sur-l’Arbresle, France).
All animal procedures were based upon the ‘‘3Rs” policy (Replace-
ment, Reduction and Refinement). The maintenance and use of
animals were in accordance to the Ethics Committee of University
of Minho, and approved by the Portuguese Licensing Authority
(DGV-DSSPA).
Scaffolds of 8 mm in diameter and 4 mm in height were used for
the subcutaneous implantation and sterilized by ethylene oxide.
Each mouse was anesthetized by intraperitoneal injection of Domi-
tor INJ 1 mg/mL (Medetomidine 1 mg/Kg, Novavet, Braga, Portugal)
and Imalgene 1000 INJ 100 mg-mL (Ketamine 75 mg/Kg, Novavet,
Braga, Portugal). The hair of the mice was removed at the implan-
tation area, followed by disinfection with iodine (Life Technologies,
Carlsbad, CA, USA). In each mouse, two skin incisions (1 cm length)
were made in the dorsal midline, close from the head (CH) and far
from the head (FH). The HRP-crosslinked SF scaffolds were then
implanted subcutaneously at both right and left sides into the
respective pockets, followed by skin suturing. Twelve specimens
were implanted. The mice were euthanized 14 and 28 days post-
surgery by injection of Eutasil 200 mg/mL (pentobarbital sodium,
Novavet, Braga, Portugal) and the implanted materials were
retrieved along with the surrounding tissue (Fig. 1d). The explants
were fixed with 10% (v/v) formalin for at least 5 days at RT and
transferred to histological cassettes for paraffin-embedding. Sam-
ples were then serially sectioned using a microtome (3.5 mm thick)developing silk fibroin scaffolds for cartilage regeneration, Acta Biomater.
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tions were observed and images acquired as described in 2.6.8.
2.8. Statistical analysis
Statistical analysis was performed using the GraphPad Prism 5.0
software (GraphPad Software, La Jolla, CA, USA). First, a Shapiro-
Wilk test was used to ascertain about the data normality. The com-
pressive modulus results from static mechanical properties were
analyzed by means of a Mann-Whitney test. A Kruskal-Wallis test,
followed by Dunn’s post-test were used to analyze the hASCs
metabolic activity, proliferation, GAGs/DNA quantification and col-
lagen content. The significance level was set to *p < 0.05, **p < 0.01,
***p < 0.001.
3. Results
3.1. Morphology and microstructure characterization
In this study, the detailed pore morphology at the HRP-
crosslinked SF scaffolds surface (Fig. 2a and b) and cross-sections
(Fig. 2c and d) were analyzed by SEM. It was observed a similarFig. 2. SEM micrographs of the (a, b) surface and respective (c, d) cross-sections of the HR
lm for high magnification images). The red arrows indicate macro-pores and the yellow a
sectional image for porosity representation, (f, g) 3D reconstruction of top and side view
thickness distribution of the HRP-crosslinked SF scaffolds. (For interpretation of the refer
article.)
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interior, mainly with two types of pore size. From Fig. 2a and c,
macro-pores with more than 500 lm in size were observed. There
were also micro-pores with less than 50 lm distributed inside the
thick macro-pore walls (Fig. 2b and d).
The qualitative and quantitative analysis of scaffolds architec-
ture were investigated by micro-CT. Table 2 demonstrates
that the HRP-crosslinked SF scaffolds presented a high porosity
(89.3 ± 0.6%) and mean pore size (361.4 ± 20.3 lm), with intercon-
nected pores (95.9 ± 0.8%) and thick pore walls (51.7 ± 2.9 lm).
The two-dimensional (2D) horizontal cross-section (Fig. 2e) and
3D reconstruction of top and side views (Fig. 2f and g) also showed
the interconnectivity and porous structure of scaffolds, confirming
the SEM observations. The micro-CT morphometric analysis
revealed a widespread pore size and wall thickness distribution
ranging from 8.79 mm to 747.32 and 114.30 mm within the scaf-
folds, respectively (Fig. 2h and i).
3.2. Chemical structure and protein conformation
The SF conformation and chemical composition in the scaffolds
were analyzed by ATR-FTIR (Fig. 3). The FTIR spectra showed twoP-crosslinked SF scaffolds (scale bars: 1 mm for low magnification images and 100
rrows indicate micro-pores (<100 lm). Micro-CT analysis showing the (e) 2D cross-
s, respectively (scale bar: 2 mm), (h) mean pore size distribution, and (i) mean wall
ences to colour in this figure legend, the reader is referred to the web version of this
developing silk fibroin scaffolds for cartilage regeneration, Acta Biomater.
Table 2
Microstructure of the HRP-crosslinked SF scaffolds determined from the micro-CT data.
Mean porosity (%) Mean pore size (mm) Mean interconnectivity (%) Mean wall thickness (mm)
HRP-crosslinked SF scaffold 89.3 ± 0.6 361.4 ± 20.3 95.9 ± 0.8 51.7 ± 2.9
Fig. 3. ATR-FTIR spectra of the HRP-crosslinked SF scaffolds.
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bance peaks are in the range assigned to amide-I and amide-II,
respectively, and can be attributed to the b-sheet conformation
of SF. A very small and hardly pronounced shoulder peak corre-
sponding to the amorphous or silk-I conformation was detected
at 1650 cm1 [39].
3.3. Mechanical properties, swelling ratio and degradation profile
As shown in Fig. 4a, the static compressive modulus of the dried
HRP-crosslinked SF scaffolds was 2.97 ± 0.90 MPa, significantlyFig. 4. (a) Box and whisker graph plot of the compressive modulus and (b) representat
hydrated state. The left and right arrows indicate the respective y-axis (compressive stres
profile of the HRP-crosslinked SF scaffolds for a period of 30 days (% weight).
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(***p < 0.01). The representative stress-strain plot (Fig. 4b) shows
the same behavior for the compressive strength of scaffolds in
dry (0.54 ± 0.05 MPa) and wet (0.03 ± 0.006 MPa) conditions.
Fig. 4c shows that the swelling ratio of the HRP-crosslinked SF
scaffolds reached an equilibrium after 6 h of immersion in PBS
(585%) solution, maintaining their weights up to 30 days. In this
study, the enzymatic degradation of the HRP-crosslinked SF scaf-
folds was analyzed by using protease XIV [40]. It was observed that
the degradation rate of scaffolds was faster in the presence of pro-
tease XIV at both tested concentrations (3.5 U/mL and 0.2 U/mL), as
compared to the control condition in which scaffolds maintained
their original weights after soaking in PBS solution for 30 days. In
the first 12 h, the degradation rate of scaffolds immersed in
protease XIV at 3.5 U/mL was higher than 50%, as compared to
the 20% weight loss in protease XIV at 0.2 U/mL. After 14 days
of degradation in protease XIV at 3.5 U/mL, scaffolds reached
100% weight loss, while the scaffolds immersed in protease XIV
at 0.2 U/mL presented 60% weight loss only after 30 days of
degradation.3.4. In vitro characterization of the HRP-crosslinked SF scaffolds
Prior differentiation, hASCs were characterized for the expres-
sion of MSCs surface markers, CD105, CD90, CD73, CD45 and
CD34. The cells showed a mesenchymal-like phenotype, exhibiting
the typical panel of markers: CD105+/CD73+/ CD90+/CD45/CD34
[37] (Supplementary Fig. 1).ive stress-strain plot of the HRP-crosslinked SF scaffolds measured in the dry and
s) of the dry and hydrated samples. (c) Swelling ratio, and (d) enzymatic degradation
developing silk fibroin scaffolds for cartilage regeneration, Acta Biomater.
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The Alamar blue assay was performed to evaluate the metabolic
activity of cells up to 28 days of culturing (Fig. 5a). In basal culture
conditions, cells presented a significant increase of metabolic activ-
ity over the 28 days of culture (*p < 0.05 from day 7 to day 14;
**p < 0.01 from day 1 to day 21; ***p < 0.001 from day 7 to day
21 and from day 1, 7, 14 to day 28). Concerning the cultures in chon-
drogenic differentiation medium, stable metabolic activity levels
were observed from day 1 to day 28. However, at day 1 and day
7, cells presented a significantly higher metabolic activity as com-
pared to that detected in basal culture conditions (a***p < 0.001).
From the live/dead staining, it was found that cells adhered to
the highly porous scaffolds and were alive over the 28 days of cul-
ture in chondrogenic and basal conditions (Fig. 5b). From day 7, a
dense cell layer spreading over the HRP-crosslinked SF constructs
was observed in both culture media. Nevertheless, at day 21 and
day 28 the presence of self-aggregated cells clusters was observed
in chondrogenic culture conditions, replacing the dispersive and
elongated morphology of cells observed in basal medium at the
same culture periods.3.4.2. Biochemical characterization
Cell proliferation was screened by DNA content analysis
(Fig. 6a). It was observed that no significant differences in cell pro-
liferation were observed from day 1 to day 28 for cells cultured in
chondrogenic differentiation medium. The DNA content signifi-
cantly increased in basal culture conditions from day 1 to day 28
(*p < 0.05: from day 7 to day 21; **p < 0.01: from day 1 to day 28;
***p < 0.001: from day 7 to day 28) presenting at day 21
(a**p < 0.01) and day 28 (b***p < 0.001) significantly higher DNA
content than in chondrogenic culture conditions.Fig. 5. (a) Box and whisker graph plot of the alamar blue metabolic activity and (b) live
scaffolds for 1, 7, 14, 21 and 28 days in chondrogenic and basal culture medium. aStatist
culture period under basal culture conditions (***p < 0.001). (For interpretation of the refe
article.)
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crosslinked SF scaffolds was normalized by their respective DNA
content (Fig. 6b). It was found a significant increase of GAG/DNA
ratio after 7 days of culture in chondrogenic differentiation med-
ium, in comparison to day 1 (**p < 0.01). No significant differences
were observed at day 14. However, after 21 days and 28 days in
chondrogenic culture conditions the GAG/DNA ratio significantly
increased as compared to day 1 (***p < 0.001). In basal culture med-
ium, only a residual GAG/DNA ratio was determined and no signif-
icant differences were observed over the 28 days of culture. In fact,
the GAG/DNA ratio determined on the HRP-crosslinked SF
constructs cultured in chondrogenic differentiation medium was
significantly higher at day 21 (b***p < 0.001) and day 28
(a***p < 0.01), as compared to that obtained in basal culture conditions.
The quantification of the proteins that integrate the ECM was
performed by Sirius red/Fast green staining kit, aiming at discrim-
inate the collagen content on the HRP-crosslinked SF constructs. In
Fig. 6c, a non-significant increase of the collagen content was
determined after 21 days of culture in chondrogenic differentiation
medium. For the HRP-crosslinked SF constructs cultured in basal
conditions, a significant increase of the collagenous proteins was
observed after 21 and 28 days of culture, as compared to day 1
(*p < 0.05), day 7 (**p < 0.01) and day 14 (***p < 0.001). When com-
paring the chondrogenic and basal culture conditions at the same
culture period, no significant differences were detected for the col-
lagen deposition at the HRP-crosslinked SF constructs.3.4.3. Chondrogenic-related markers expression, extracellular matrix
composition and dynamic mechanical properties after culturing
The differentiation of hASCs seeded onto the HRP-crosslinked SF
scaffolds was evaluated by quantifying the mRNA expression of the/dead staining (scale bar: 200 lm) of the hASCs cultured on the HRP-crosslinked SF
ically significant when compared to the HRP-crosslinked SF constructs at the same
rences to colour in this figure legend, the reader is referred to the web version of this
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Fig. 6. Box and whisker graph plot of the (a) DNA quantification, (b) GAG’s content normalized against the amount of DNA, and (c) collagenous proteins quantification at the
HRP-crosslinked SF scaffolds cultured with hASCs in chondrogenic and basal medium for 1, 7, 14, 21 and 28 days. a,bStatistically significant when compared to the HRP-
crosslinked SF constructs at the same culture period under basal culture conditions (a***p < 0.01, b***p < 0.001).
10 V.P. Ribeiro et al. / Acta Biomaterialia xxx (2018) xxx–xxxchondrogenic-related markers, collagen type II (Col II), Sox-9 and
Aggrecan (ACAN) (Fig. 7a). The mRNA transcripts evaluated after
28 days of culture in basal and chondrogenic differentiation med-
ium, revealed the expression of all chondrogenic-related markers
after culturing the HRP-crosslinked SF constructs in chondrogenic
differentiation medium. In contrast, no mRNA expression was
detected for the same markers in basal culture conditions.
Complementary, the immunodetection of Col II, Sox-9 and
ACAN at the HRP-crosslinked SF constructs was also evaluated
(Fig. 7b). The immunofluorescence images show an intense protein
expression of all chondrogenic-related markers after 28 days of
culture in chondrogenic differentiation medium. However, in basal
culture conditions only a residual expression of Col II, Sox-9 and
ACAN was detected.Please cite this article in press as: V.P. Ribeiro et al., Combinatory approach for
(2018), https://doi.org/10.1016/j.actbio.2018.03.047The newly formed ECM at the HRP-crosslinked SF constructs
was evaluated and sections stained to visualize the GAGs secretion
and collagen deposition (Fig. 7c). After 28 days of culture, only the
ECM formed on the HRP-crosslinked SF constructs cultured in
chondrogenic differentiation medium was intensely stained for
GAGs, as observed from the intense Alcian blue and positive
staining for Safranin-O. Moreover, from the Masson’s trichome
and Sirius red staining’s it was possible to observe a well
pronounced collagen matrix deposited on the HRP-crosslinked SF
constructs cultured both under chondrogenic and basal culture
conditions.
The dynamic viscoelastic properties of the HRP-crosslinked SF
scaffolds and constructs after 28 days of culture in chondrogenic
differentiation medium were assessed by DMA (Fig. 7d), in orderdeveloping silk fibroin scaffolds for cartilage regeneration, Acta Biomater.
Fig. 7. HRP-crosslinked SF scaffolds after 28 days of culturing with hASCs in chondrogenic and basal medium. (a) Box and whisker graph plot of the real-time PCR results of
Col II, Sox-9 and ACAN. Relative gene expression was normalized to the reference gene GAPDH and calibrated to the data of each gene at day 1 in basal conditions. # Indicate
the non-expression of the target genes under basal culture conditions. (b) Immunofluorescence analysis of the chondrogenic-related markers. Nuclei are stained in blue, Col II
and ACAN in green, and Sox-9 in red (scale bar: 50 lm). (c) Histological analysis of the HRP-crosslinked SF constructs. Alcian blue (blue) and Safranin-O (red) staining were
used to detect GAGs formation, Masson‘s trichome (blue) and Sirius red (red) staining were used for the visualization of collagen at the ECM (scale bar: 100 lm). The red
arrows indicate the stained scaffolds. (d) Storage modulus (E’) and loss factor (tan d) of the HRP-crosslinked SF scaffolds and constructs determined in chondrogenic
differentiation medium. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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scaffolds for cell-free and cell-based approaches in cartilage TE
applications. It was observed that the storage modulus (E’) of the
HRP-crosslinked SF scaffolds and constructs slightly increased
from 0.17 ± 0.06 to 0.22 ± 0.10 MPa and 0.19 ± 0.02 to 0.27 ± 0.03
MPa, respectively, as the frequency increased from 0.1 to 10 Hz.
In the frequency range tested the E’ values of the HRP-
crosslinked SF constructs were higher than those obtained for the
scaffolds. Comparing the loss factor (tan d) results, it was found
that both groups presented stable and high tan d values for the
tested frequencies. Nevertheless, it was found that the HRP-
crosslinked SF scaffolds presented higher tan d values than
constructs.3.5. Subcutaneous implantation of the HRP-crosslinked SF scaffolds
The in vivo compatibility of the HRP-crosslinked SF scaffolds
was assessed by subcutaneous implantation in a mice model
(Fig. 8). The macroscopic images of the explants showed that
scaffolds were still integrated in the subcutaneous tissue after 14
(Fig. 8a) and 28 (Fig. 8b) days of implantation, maintaining their
shape and integrity over the implantation periods. From the low
magnification H&E staining images (Fig. 8c and d), it was observed
that a thick layer of connective tissue adhered on the entire surface
of the scaffolds and deeply infiltrated into the porous structures.
The high magnification H&E staining images (Fig. 8e–h) allowed
confirming the presence of connective tissue filling the inner pores
of the scaffolds. The absence of edema or signs of neutrophils afterPlease cite this article in press as: V.P. Ribeiro et al., Combinatory approach for
(2018), https://doi.org/10.1016/j.actbio.2018.03.047the implantation periods, revealed that no acute inflammation was
induced by the HRP-crosslinked SF scaffolds.4. Discussion
In natural cartilage tissue, the ECM provides a complex environ-
ment of physical, chemical and mechanical cues that directly affect
and guide cell behavior. In the recent years, SF has demonstrated to
be a robust natural material widely explored for bone [41], carti-
lage [27] and osteochondral [42] TE. Its processing versatility
allowed to extend the use of SF for TE applications of ligament
[43], blood vessels [44] or skin [45]. Several methods have been
individually applied to prepare silk scaffolds [41,44,46], frequently
with the limitation of poorly mimicking the structural and
mechanical complexity of tissues like cartilage. The salt-leaching
method is widely used due to the effective processing and gener-
ated controlled porosity in a wide range of pore sizes [47]. More-
over, the behavior of SF in the presence of NaCl is affected by the
salt ions extracting the water that usually coat the hydrophobic
domains in the b-sheet structure of the protein. This would
promote chain-chain interactions resulting in protein folding and
b-sheet formation [48,49]. Salt-leached silk scaffolds generally
present high stiffness due to the presence of silk II (b-sheet confor-
mation) formation. For example, Kim et al. [48] developed
aqueous-derived SF scaffolds prepared using salt-leaching and
freeze-drying methodologies, showing that scaffolds had con-
trolled pore size, interconnectivity and adjustable mechanical
properties. In a different study, Nazarov et al. [46] individuallydeveloping silk fibroin scaffolds for cartilage regeneration, Acta Biomater.
Fig. 8. Subcutaneous implantation of the HRP-crosslinked SF scaffolds in mice. Macroscopic images of the explants after implantation for (a) 14 days and (b) 28 days (scale
bar: 10 mm). H&E staining of the SF scaffold explants after (c, e, g) 14 days and (d, f, h) 28 days of implantation (scale bars: 1 mm for lowmagnification images and 100 lm for
high magnification images). Black squares represent the regions corresponding to the implanted HRP-crosslinked SF scaffolds. Red squares represent the regions
corresponding to the magnified stained images (e–h). The black arrows indicate connective tissue, the red arrows indicate the stained scaffolds. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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porous 3D silk biomaterials, stating that different matrices can be
produced according to the processing method and conditions.
Moreover, these authors also showed that to induce b-sheet struc-
ture and water insolubility after lyophilization, a methanol treat-
ment was induced to the aqueous SF before freeze-drying
processing. In our study, the crystallinity of the HRP-crosslinked
SF solution was ensured with the salt-leaching processing, avoid-
ing the return to an amorphous and gel state after re-hydration
of the freeze-dried scaffolds, as confirmed by FTIR analysis
(Fig. 3). According to different authors [13,14], scaffolds designed
for cartilage TE should include optimal structural and mechanical
properties, controlled degradability rate and good adaptability to
the defect site, showing that highly porous SF scaffolds developed
by salt-leaching and freeze-drying methodologies can fit to these
criteria. In a previous study by our group [27], salt-leached and
freeze-dried SF scaffolds prepared in a range of high-
concentration aqueous SF solutions, showed stable degradability
and improved mechanical properties for meniscus and cartilage
regeneration. Nevertheless, to fully recreate the microenvironment
found in cartilage tissue, there is a need to better control the stiff-
ness of the salt-leached SF scaffolds. Until now, SF hydrogels have
been seen as potential matrices for cartilage applications present-
ing a biomimetic aqueous matrix responsible for its resilient and
elastic behavior [12]. However, these matrices can also be less
stable for cell culture applications, raising the hypothesis of creat-
ing novel SF biomaterials that match the stiffness of soft SF hydro-
gels with the porosity and mechanical stability of salt-leached SF
scaffolds. In a recent study, agarose/SF blended hydrogels were
structured by freeze-drying methodology to create porous struc-
ture of hydrogels, showing the typical elastic behavior of blended
hydrogels but at the same time a reinforcement and stability
induced by the microporous structures [7]. Moreover, the cellular
studies demonstrated that chondrocytes cultured in the structures
with larger pores induced higher cartilage-specific ECM produc-
tion. To achieve this effect, the herein proposed scaffolds resulted
from a combination of enzymatically crosslinked SF hydrogels with
salt-leaching and freeze-drying technologies to create a highly por-
ous, stable and yet stiff hydrogel-based system for specific carti-
lage TE applications. As demonstrated by the SEM (Fig. 2a–d) and
micro-CT (Fig. 2e–i and Table 2) analysis not only a high porosity
was observed within the HRP-crosslinked SF scaffolds, as different
pores sizes were achieved. Considering the wide size range of the
sodium chloride particles used for salt-leaching processing, it was
expected that the pore size of the scaffolds would not be homoge-Please cite this article in press as: V.P. Ribeiro et al., Combinatory approach for
(2018), https://doi.org/10.1016/j.actbio.2018.03.047neous, even presenting a homogeneous distribution along the scaf-
folds (Fig. 2h). Moreover, the thick pore walls (51.7 ± 2.9 lm)
induced by the highly concentrated aqueous SF solution, also
demonstrated small pores (<50 lm) distributed inside the struc-
tures (Fig. 2b and d) that can result from the recrystallization of
the dissolved salt particles (leaching process) combined with the
freeze-drying process [27]. This wide range of pore size is of great
interest for cartilage TE, especially due to the lack of self-
remodeling capacity of cartilage tissue that naturally present small
pores (2.5 to 6.5 nm). Pores with sizes inferior to 50 lm are recom-
mended to improve cell adhesion and seeding efficiency, whereas
larger and interconnected pores improve cellularity and ECM
ingrowth for faster constructs development [50]. As reported by
Vikingsson et al. [51] different pore sizes and wall thickness within
the micro-architecture can directly affect the mechanical proper-
ties and degradation profile of scaffolds. In a previous study, Han
et al. [8] observed that the compressive strength of salt-leached/
freeze-dried SF scaffolds produced with aqueous SF solutions of
4–5 wt%, decreased from 1.6 to 1.09 MPa as the pore size increased
(90–180 lm to 355–425 lm). This was an expected result, since a
lower macro-porosity induce the formation of denser structures
that can withstand higher loads. As observed in our study, Kim
et al. [48] also showed a compressive modulus of 3.33 ± 0.5 MPa
and a compressive strength of 0.32 ± 0.01 MPa on dried salt-
leached/freeze-dried SF scaffolds, produced with high concentra-
tion SF solution (10 wt%) and bigger particle sizes (1,000–1,180
lm). An important role is also attributed to the b-sheet content
of SF scaffolds. In the present study, superior b-sheet content and
less amount of amorphous conformation was detected by FTIR
(Fig. 3), which may have influenced the mechanical properties of
the produced scaffolds. In a different study performed by Yao
et al. [52], the compressive modulus and compressive strength of
salt-leached SF scaffolds was higher on samples with higher silk
II (b-sheet crystal) formation. Yan et al. [16], also showed that
the compressive modulus of the HRP-crosslinked SF hydrogels
with b-sheet conformation (1.12 MPa), was significantly higher
than that of random coil hydrogels (0.022 MPa). When compared
to the compressive modulus of the crystalline HRP-crosslinked SF
scaffolds, both presented similar compressive modulus to the
native human articular cartilage tissue (ranging from 1.16 to
7.75 MPa in deep, from the articular surface) [53].
It is well-established that implantable scaffold materials should
be able to absorb the nutrients and metabolites from the adjacent
tissue. Moreover, the swelling process is also necessary to press-fit
the construct at the implantation site, improving the fluidicdeveloping silk fibroin scaffolds for cartilage regeneration, Acta Biomater.
V.P. Ribeiro et al. / Acta Biomaterialia xxx (2018) xxx–xxx 13exchanges [40]. At the same time, the constructs should be able to
restore the biomechanical function and maintain a controllable
degradation during the stages of manipulation and thereafter.
Biomaterials degradation in the living environment is a com-
plex phenomenon that involves several synergistic pathways,
either enzymatic or chemical [54]. Thus, the in vitro degradation
should provide a realistic clue of the functional interaction
between the construct and the biological environment. Protease
XIV have been used for in vitro degradation studies involving SF
structures [42,54]. This enzyme has no specific activity towards
the chemical structure and amino acid sequence of SF, which
makes it more aggressive to better mimic the in vivo conditions
that simultaneously involve the activity of several enzymes (chy-
motrypsin, collagenase, etc.) [55]. In the present study, we have
proposed HRP-crosslinked SF scaffolds with large swelling capacity
and able to maintain a swelling stability and structural integrity
over 30 days (Fig. 4c). In our previous study, we also found that
the HRP-mediated SF hydrogels are pH responsive maintaining
their original weights and structure at physiological conditions
[25]. In a different study, Yan et al. [16] observed that random coil
SF hydrogels presented higher swelling capacity than the crys-
talline SF hydrogels, due to the aggregated SF molecules formed
with the b-sheet induction that make the hydrogels more
hydrophobic. Moreover, these strong hydrophobic interactions
may have rendering the protease XIV more inaccessible for prote-
olytic cleavage, affecting the degradation of the crystalline SF
hydrogels, which presented only 5% weight loss after 12 h in pro-
tease XIV solution (0.2 U/mL), as compared to the faster degrada-
tion of the random coil SF hydrogels. Our results showed a
greater impact on the HRP-crosslinked SF scaffolds degradation
at the highest tested concentration of protease XIV (3.5 U/mL),
reaching 100% weight loss after 14 days in degradation solution.
However, the degradation profile tested with 0.2 U/mL of enzyme,
showed a 19% weight loss within 12 h, which can be explained by
the high porosity and mean pore size (Table 2) attributed to the
salt-leaching processing [56]. In a previous study by our group
[42], it was observed that SF scaffolds derived from highly concen-
trated aqueous SF solution (16 wt%) and processed through salt-
leaching (500–1,000 mm sodium chloride particles size) and
freeze-drying technologies, presented a much faster degradation
rate as compared to the HRP-crosslinked SF scaffolds. In this case,
the covalent bonds established between the tyrosine groups in the
enzymatic crosslinking process can difficult the proteolytic cleav-
age induced by the protease XIV, making the degradation process
slower and more controlled [16,25]. These results correlate well
with the literature, stating that the degradation properties of scaf-
folds should be tailored to match the target tissue regeneration [1].
Considering the limited self-remodeling capacity of cartilage tis-
sue, a slower degradation profile of the HRP-crosslinked SF scaf-
folds can be appropriate for cartilage scaffolding strategies.
Successful cell-based TE strategies for the repair of critical-sized
cartilage defects also require a safe and easily accessible cell source
for in vitro chondrogenesis and eventually functional integration
in vivo [57]. Human ASCs have demonstrated a significant potential
for chondrogenic differentiation, using different scaffolding strate-
gies as platforms [33,58]. Nevertheless, as reported in previous
studies, a wide range of scaffolds pore size can induce different cell
behaviors [7,8]. In this study, we were able to observe the effects of
scaffolds micro-porosity on a good cell adhesion and spreading at
the surface, as well as, cells infiltrating the interconnected large
pores to colonize the scaffolds interior (Fig. 5b). In chondrogenic
differentiation medium it was possible to observe that the porous
3D environment induced cell clusters formation, typically found
during cartilage development [59]. Han et al. [8] also observed that
salt-leached SF scaffolds produced with different pore size had dis-
tinct influence on chondrocytes behavior. Scaffolds with smallerPlease cite this article in press as: V.P. Ribeiro et al., Combinatory approach for
(2018), https://doi.org/10.1016/j.actbio.2018.03.047pore size improved cell adhesion and presented the highest levels
of GAGs and collagen content, whereas the scaffolds with higher
pore size provided the best environment for cell proliferation. In
our study, cell proliferation was stable until day 14 on both chon-
drogenic and basal culture conditions, however, at day 21 and day
28 significantly higher DNA values were detected in basal culture
conditions, as compared to HRP-crosslinked SF constructs in chon-
drogenic differentiation medium (Fig. 6a). These results corrobo-
rate the metabolic activity (Fig. 5a) and live/dead (Fig. 5b)
observations, suggesting the differentiation of hASCs in the HRP-
crosslinked SF constructs under chondrogenic culture conditions.
Confirming these observations, the amount of released GAGs by
the chondrogenic-induced hASCs at day 21 and day 28 was signif-
icantly higher than that in basal culture conditions (Fig. 6b). More-
over, the quantification of collagen content showed the same
tendency for an increase of protein deposition until day 21
(Fig. 6c). Previous studies, showed the positive influence of the
porous-like structure of SF scaffolds on hASCs chondrogenic differ-
entiation and cartilage-specific ECM production [33,34]. For exam-
ple, Kim et al. [33] observed that chondrogenic-induced hASCs
were able to produce higher GAGs and collagen content on salt-
leached SF scaffolds, as compared to those in the conventional
micromass pellet culture system [60].
In vitro chondrogenic differentiation is characterized by the
genotypic (Fig. 7a) and phenotypic (Fig. 7b) expression of
cartilage-specific markers. Col II is the most common type of colla-
gen at the hyaline cartilage, and together with ACAN are two of the
most important components of cartilage ECM. Sox-9 is a key tran-
scription factor in chondrogenesis able to directly regulate the
expression of Col II and ACAN [14]. In this study, the analysis of
Col II, Sox-9 and ACAN showed their expression after 28 days of
culturing in chondrogenic differentiation medium, which may be
indicative of hASCs chondrogenic differentiation on the HRP-
crosslinked SF constructs. This behavior has been reported in other
studies [33,34] and is also in agreement to the GAGs (Fig. 6b) and
collagen (Fig. 6c) quantification results. Moreover, the non-
expression of these markers under basal culture conditions also
corroborates to this hypothesis.
The GAGs secreted by the chondrogenic-induced hASCs were
also confirmed by histological analysis (Fig. 7c). However, the col-
lagen deposition was shown at similar levels on both chondrogenic
and basal culture conditions, which is not in agreement to the
results obtained for Col II expression (Fig. 7a and b). In fact, it is
well known that other type of collagen is associated with the
ECM of undifferentiated cells [61]. Therefore, the total collagen
quantified (Fig. 6c) and visualized (Fig. 7c) at the ECM of the
HRP-crosslinked SF constructs cultured in basal medium may not
correspond to the Col II observed in chondrogenic culture condi-
tions. After 28 days of culture in chondrogenic differentiation med-
ium, a slight increase of the storage modulus was determined on
the HRP-crosslinked SF constructs, as compared to the non-
seeded scaffolds (Fig. 7d), which can be explained by the presence
of the newly formed ECM. Nevertheless, there were no statistical
differences in respect to the mechanical properties with or without
chondrogenic cell culture, which represents the ability of scaffolds
to maintain their mechanical performance during tissue regenera-
tion [27]. Considering that a healthy articular cartilage sustains
physiological stresses that can range from 1 to 10 MPa, the pro-
posed HRP-crosslinked SF constructs can be suggested as tempo-
rary cartilage tissue substitutes [62]. The loss factor results
(Fig. 7d), also confirmed the viscoelastic nature of both HRP-
crosslinked SF scaffolds (ranging from 0.8 to 0.74) and constructs
(ranging from 0.49 to 0.50), which means that the proposed struc-
tures can completely recover from high physical loads, which is an
important concern considering that articular cartilage of joints are
highly stimulated mechanically, from the daily walking to thedeveloping silk fibroin scaffolds for cartilage regeneration, Acta Biomater.
14 V.P. Ribeiro et al. / Acta Biomaterialia xxx (2018) xxx–xxxactive loading sports [2]. Moreover, these results suggest that these
structures can be easily adjusted to fulfill cartilage defects and
facilitate surgical interventions.
The compatibility between the HRP-crosslinked SF scaffolds and
in vivo tissues evaluated by subcutaneous implantation, showed
good scaffolds integrity and dimensional stability during the
implantation periods (Fig. 8a and b). The crystalline structure of
scaffolds, confirmed by FTIR (Fig. 3) analysis, may have influenced
the obtained results. Moreover, the stable degradation profile of
the HRP-crosslinked SF scaffolds (Fig. 4d), also corroborates to this
hypothesis. In a previous study by our group [42], the in vivo com-
patibility of bilayered SF/SF-nanoCaP scaffolds was also tested by
subcutaneous implantation up to 28 days, showing that the crys-
talline structure of SF allied to the suitable mechanical properties
of scaffolds maintained their stability and shapes during the
implantation period. A thick layer of connective tissue was
observed surrounding and deeply infiltrating the HRP-crosslinked
SF scaffolds (Fig. 8e–h). The high porosity and interconnectivity
revealed by SEM (Fig. 2a–d) and micro-CT (Fig. 2e–i and Table 2)
analysis may have contributed to these results [41,42]. For exam-
ple, Yan et al. [42] have also demonstrated the positive influence
of highly porous structures to support tissue ingrowth on bilayered
SF/SF-nanoCaP scaffolds. The surface chemistry of SF is known for
providing good cell behavior and biocompatibility in vivo [41],
showing that the in vitro and in vivo performance of the HRP-
crosslinked SF scaffolds may not be only related to the architecture
and morphological features of constructs, but also to the physical
and chemical properties of SF [63]. The versatility of the present
combined technologies, and the possibility of incorporating inor-
ganic materials can encourage extending their application in differ-
ent regenerative strategies, in particular, for developing monolithic
and hierarchical structures for osteochondral regeneration.
A number of limitations of the present study offer opportunities
for additional research. First, a control condition using macro-/
micro-porous SF scaffolds produced with pure SF solution (16 wt
%) would allow to be compared with the proposed HRP-
crosslinked SF scaffolds. Also, this study focused on the effect of
using established concentrations of SF/HRP/H2O2. The concentra-
tions could be changed (in proportion) in order to evaluate the
effects over scaffolds mechanical properties and degradation pro-
file [25]. Additionally, testing a range of macro-porosity induced
by the salt-leaching processing would be of great interest. Finally,
an in vivo study performed to evaluate if the HRP-crosslinked SF
scaffolds support cartilage regeneration, and understand how the
dynamic mechanical properties of constructs are affected after
implantation, are potential areas of future works.5. Conclusions
This study proposed novel HRP-crosslinked SF scaffolds devel-
oped in combination with the salt-leaching and freeze-drying tech-
nologies, for cartilage regeneration applications. These scaffolds
presented suitable porosity and mechanical properties for cartilage
scaffolding strategies, as well as, large swelling capacity and struc-
tural integrity after 30 days at physiological conditions. The scaf-
folds supported the attachment, viability and proliferation of
human adipose-derived stem cells (hASCs) in vitro. The chondro-
genic differentiation on the HRP-crosslinked SF scaffolds was rep-
resented by the peak of GAGs produced by the seeded hASCs
after 21 days of chondrogenic culture. Additionally, the genotypic
and phenotypic expression of chondrogenic-related markers, allied
to the deposition of cartilage-specific ECM, also confirmed these
observations. The HRP-crosslinked SF scaffolds maintained their
original morphology and allowed tissue ingrowth when subcuta-
neously implanted in mice. Although complementary studies arePlease cite this article in press as: V.P. Ribeiro et al., Combinatory approach for
(2018), https://doi.org/10.1016/j.actbio.2018.03.047necessary to biomechanically evaluate the anisotropic properties
of the scaffolds, as well as, in vivo validate their efficacy and stabil-
ity in articular cartilage defects, the results from scaffolds charac-
terization, in vitro chondrogenic differentiation of hASCs at the
HRP-crosslinked SF scaffolds and preliminary in vivo data, confirm
that these can be promising structures for cartilage regeneration
applications. Moreover, the multitude of structural, mechanical
and biological parameters that can be achieved through these com-
bined technologies can also encourage to extend their applicability
for different TE strategies, including for osteochondral
regeneration.
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